1. 1079. Casirivimab and Imdevimab (CAS + IMD) Antibody Combination for the Treatment of Immunocomprised Hospitalized Patients with COVID-19. (15th December 2022) Authors: Somersan-Karakaya, Selin; Mylonakis, Eleftherios; Oviedo-Orta, Ernesto; O'Brien, Meagan P; Casullo, Veronica Mas; Mou, Jenni; Xiao, Jing; Bhore, Rafia; Mahmood, Adnan; Hooper, Andrea T; Hussein, Mohamed; Ali, Shazia; Forleo-Neto, Eduardo; Herman, Gary A; Hirshberg, Boaz; Weinreich, David M Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Comparative Assessment of a Single Dose and a 2-dose Vaccination Series of a Quadrivalent Meningococcal CRM-conjugate Vaccine (MenACWY-CRM) in Children 2–10 Years of Age. Issue 1 (January 2016) Authors: Johnston, William; Essink, Brandon; Kirstein, Judith; Forleo-Neto, Eduardo; Percell, Sandra; Han, Linda; Keshavan, Pavitra; Smolenov, Igor Journal: Pediatric infectious disease journal Issue: Volume 35:Issue 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age. Issue 1 (January 2015) Authors: Zedda, Luisanna; Forleo-Neto, Eduardo; Vertruyen, André; Raes, Marc; Marchant, Arnaud; Jansen, Wim; Clouting, Heather; Arora, Ashwani; Beatty, Mark E.; Galli, Grazia; Del Giudice, Giuseppe; Castellino, Flora Journal: Pediatric infectious disease journal Issue: Volume 34:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age. Issue 1 (January 2015) Authors: Zedda, Luisanna; Forleo-Neto, Eduardo; Vertruyen, André; Raes, Marc; Marchant, Arnaud; Jansen, Wim; Clouting, Heather; Arora, Ashwani; Beatty, Mark E.; Galli, Grazia; Del Giudice, Giuseppe; Castellino, Flora Journal: Pediatric infectious disease journal Issue: Volume 34:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial. Issue 10 (October 2022) Authors: Herman, Gary A; O'Brien, Meagan P; Forleo-Neto, Eduardo; Sarkar, Neena; Isa, Flonza; Hou, Peijie; Chan, Kuo-Chen; Bar, Katharine J; Barnabas, Ruanne V; Barouch, Dan H; Cohen, Myron S; Hurt, Christopher B; Burwen, Dale R; Marovich, Mary A; Musser, Bret J; Davis, John D; Turner, Kenneth C; Mahmood,... Journal: Lancet infectious diseases Issue: Volume 22:Issue 10(2022) Page Start: 1444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study. Issue 9 (1st September 2016) Authors: Bart, Stephan; Cannon, Kevin; Herrington, Darrell; Mills, Richard; Forleo-Neto, Eduardo; Lindert, Kelly; Abdul Mateen, Ahmed Journal: Human vaccines & immunotherapeutics Issue: Volume 12:Issue 9(2016) Page Start: 2278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Non-inferiority of mammalian cell-derived quadrivalent subunit influenza virus vaccines compared to trivalent subunit influenza virus vaccines in healthy children: a phase III randomized, multicenter, double-blind clinical trial. (December 2015) Authors: Hartvickson, Robyn; Cruz, Marilou; Ervin, John; Brandon, Donald; Forleo-Neto, Eduardo; Dagnew, Alemnew F.; Chandra, Richa; Lindert, Kelly; Mateen, Ahmed Abdul Journal: International journal of infectious diseases Issue: Volume 41(2015:Dec.) Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19. (September 2022) Authors: Isa, Flonza; Forleo-Neto, Eduardo; Meyer, Jonathan; Zheng, Wenjun; Rasmussen, Scott; Armas, Danielle; Oshita, Masaru; Brinson, Cynthia; Folkerth, Steven; Faria, Lori; Heirman, Ingeborg; Sarkar, Neena; Musser, Bret J.; Bansal, Shikha; O'Brien, Meagan P.; Turner, Kenneth C.; Ganguly, Samit; Mahmood... Journal: International journal of infectious diseases Issue: Volume 122(2022) Page Start: 585 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants. (8th September 2020) Authors: Simões, Eric A F; Forleo-Neto, Eduardo; Geba, Gregory P; Kamal, Mohamed; Yang, Feng; Cicirello, Helen; Houghton, Matthew R; Rideman, Ronald; Zhao, Qiong; Benvin, Sarah L; Hawes, Alicia; Fuller, Erin D; Wloga, Elzbieta; Pizarro, Jose M Novoa; Munoz, Flor M; Rush, Scott A; McLellan, Jason S; Lipsic... Journal: Clinical infectious diseases Issue: Volume 73:Number 11(2021) Page Start: e4400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗